SAB Biotherapeutics logo

SAB Biotherapeutics

SABSNASDAQ

SAB Biotherapeutics is a biotechnology company in the healthcare sector on NASDAQ, led by Samuel J. Reich, with a market cap of $181.4M. As of Q3 2025, 269% of shares are held by 34 institutional investors, with Vivo Capital, LLC as the largest holder at 100.0%.

Chief Executive OfficerSamuel J. Reich
Market Cap$181.4M
Biotechnology
Healthcare
Employees57.0
Websitesab.bio
Country
United States of America

Overview

Overview of institutional ownership in SABS as of Q3 2025 with a market cap of $20.9M

All Institutions

Institutions
34
Value Held
$56.3M
Shares Held
28.0M
Avg Position
$1.7M
Median Position
$30.9K

Hedge Funds

Hedge Funds
7
Value Held
$28.4M
Shares Held
14.1M
Avg Position
$4.1M
Median Position
$4.4M

Ownership Breakdown

Institutional (non-HF): 133.28%Institutional (non-HF)Hedge Funds: 135.90%Hedge FundsRetail & Other: -
Institutional (non-HF)
133.28%
$27.9M
Hedge Funds
135.9%
$28.4M
Retail & Other
-
-

Based on market cap of $20.9M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in SABS as of Q3 2025

InstitutionPosition Value
Vivo Capital, LLC logo
Vivo Capital, LLC
Venture Capital
$23.0M
1.85% of portfolio
RA CAPITAL MANAGEMENT, LLC logo
RA CAPITAL MANAGEMENT, LLC
Hedge FundLong/Short
$8.8M
0.11% of portfolio
COMMODORE CAPITAL LP logo
COMMODORE CAPITAL LP
Hedge FundLong/Short
$8.8M
0.43% of portfolio
Woodline Partners LP logo
Woodline Partners LP
Hedge FundLong/Short
$5.7M
0.03% of portfolio
Sessa Capital IM, L.P. logo
Sessa Capital IM, L.P.
Hedge FundLong/Short
$4.4M
0.11% of portfolio
B
BVF INC/IL
Institution
$1.9M
0.08% of portfolio
$1.1M
0.27% of portfolio
$735.2K
0.00% of portfolio
$618.1K
0.00% of portfolio
A
AWM Investment Company, Inc.
Hedge FundEvent Driven
$402.0K
0.04% of portfolio

Net Capital Flow

Institutional buying and selling activity for SABS in Q3 2025

Traded
+$52.5M
Buyers
22
Sellers
6
Total Bought
+$52.5M
Total Sold
$59.6K
Avg Position
$1.5M

Biggest Buyers

InstitutionNet Bought
Vivo Capital, LLC logo
Vivo Capital, LLC
Venture Capital
+$23.0M
+11.4M shares
RA CAPITAL MANAGEMENT, LLC logo
RA CAPITAL MANAGEMENT, LLC
Hedge FundLong/Short
+$8.8M
+4.4M shares
COMMODORE CAPITAL LP logo
COMMODORE CAPITAL LP
Hedge FundLong/Short
+$8.8M
+4.4M shares
Woodline Partners LP logo
Woodline Partners LP
Hedge FundLong/Short
+$5.7M
+2.9M shares
Sessa Capital IM, L.P. logo
Sessa Capital IM, L.P.
Hedge FundLong/Short
+$3.5M
+1.7M shares
+$1.1M
+566.4K shares
+$618.1K
+307.5K shares
A
AWM Investment Company, Inc.
Hedge FundEvent Driven
+$402.0K
+200.0K shares
+$167.6K
+83.4K shares
+$140.3K
+69.8K shares

Biggest Sellers

InstitutionNet Sold
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$29.9K
17.1K shares
$20.8K
11.9K shares
Sachetta, LLC logo
Sachetta, LLC
RIA/Wealth
$7.2K
4.1K shares
B
BlackRock, Inc.
Institution
$1.3K
667.0 shares
$234.1
113.0 shares
$79.0
45.0 shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited SABS in Q3 2025

New Positions
7
New Value
$30.3M
Exited Positions
4
Exited Value
$58.0K

New Positions

InstitutionPosition Value
Vivo Capital, LLC logo
Vivo Capital, LLC
Venture Capital
$23.0M
11.4M shares
Woodline Partners LP logo
Woodline Partners LP
Hedge FundLong/Short
$5.7M
2.9M shares
$1.1M
566.4K shares
A
AWM Investment Company, Inc.
Hedge FundEvent Driven
$402.0K
200.0K shares
$31.7K
15.8K shares
A
ADAR1 Capital Management, LLC
Hedge FundLong/Short
$30.2K
15.0K shares
C
CAXTON CORP
Institution
$22.0K
10.9K shares

Exited Positions

InstitutionPrevious Position
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$29.9K
17.1K shares
$20.8K
11.9K shares
Sachetta, LLC logo
Sachetta, LLC
RIA/Wealth
$7.2K
4.1K shares
$79.0
45.0 shares

Options Activity

Institutions with the largest Call and Put options positions in SABS as of Q3 2025

Call Positions
0
Call Value
-
Put Positions
0
Put Value
-

Call Positions

InstitutionPosition Value
No call positions found

Put Positions

InstitutionPosition Value
No put positions found

Most Committed Institutions

Institutions with SABS as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
Vivo Capital, LLC logo
Vivo Capital, LLC
Venture Capital
1.85%
$23.0M
COMMODORE CAPITAL LP logo
COMMODORE CAPITAL LP
Hedge FundLong/Short
0.43%
$8.8M
0.27%
$1.1M
Sessa Capital IM, L.P. logo
Sessa Capital IM, L.P.
Hedge FundLong/Short
0.11%
$4.4M
RA CAPITAL MANAGEMENT, LLC logo
RA CAPITAL MANAGEMENT, LLC
Hedge FundLong/Short
0.11%
$8.8M
C
CAXTON CORP
Institution
0.10%
$22.0K
B
BVF INC/IL
Institution
0.08%
$1.9M
A
AWM Investment Company, Inc.
Hedge FundEvent Driven
0.04%
$402.0K
Woodline Partners LP logo
Woodline Partners LP
Hedge FundLong/Short
0.03%
$5.7M
F
0.01%
$38.2K

Hedge Fund Spotlight

Discover hedge funds investing in SABS

COMMODORE CAPITAL LP logo
COMMODORE CAPITAL LP
Hedge FundLong/Short
Portfolio ManagerMichael Jonathan Kramarz
Portfolio Value
$2.0B
Positions
37
Last Reported
Q3 2025
AddressNew York, NY
Sector Allocation
Healthcare: 93.20%Healthcare
SAB Biotherapeutics logo

Position in SAB Biotherapeutics

Market Value
$8.8M
Shares Held
4.4M
Portfolio Weight
0.43%
Owned Since
2025-Q3
Top HoldingSectorMarket ValueWeight
Biotechnology
Healthcare
$331.9M16.20%
Biotechnology
Healthcare
$121.1M5.91%
Biotechnology
Healthcare
$108.4M5.29%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.